Upcoming Presentations:

07.07.2009 Gordon Conference on Virus and Cells, Lucca (Barga). Italy

06.25.2008 Biodetection Technologies Technological Responses to Biological Threats, Maryland. USA

*****************************************************************************

Past Meetings and Presentations:

01.18.2009 Gordon Conference on Chemical and Biological Terrorism, Huston, TX. USA.

11.13.2008 Scientific Conference on Chemical & Biological Defense Research, New Orleans, LA. USA.

07.05.2008 Biodefense Technology Conference, Barcelona. Spain

11.13.2007 Scientific Conference on Chemical & Biological Defense Research, Maryland, MD. USA.
11.01.2007 11th International Conference Detection Technologies. San Diego, CA USA
08.14.2007CHI's Point-of-Care Diagnostics. Washington. DC USA
07.29.2007Structural, Functional and Evolutionary Genomics. Cambridge, United Kingdom
06.21.2007CHI's RNA Interference: From Therapeutic Targets to Diease. San Francisco, California
06.03.2007 Gordon Conference on Viruses and Cells. Tilton, New Hampshire
05.30.2007 Federal CBRN Detection R&D Opportunities Conference. Washington. DC
04.13.2007 CHI's MICROARRAYS IN MEDICINE. Boston, Massachusetts

03.02.2007 Orion Integrated Biosciences Inc announced the operations of its Agricultural Division in Peru. Fourteen agronomists will provide value added services in the areas of crop science, plant breeding and integrated pest management for Peruvian farmers producing high value crops. These activities coupled with the research-and-development (R&D) efforts on new elite germplasm, genomics research, and the commercialization of new generation of agrochemicals seek to increase farm income, and promote more opportunities for sustainable farming. Orion's CEO Willy Valdivia-Granda pointed "we are delighted to provide new services and operate in Peru. As this country's economy continues to growth, we believe our commitment to this area mark a new activity to increase our revenues and provide services totaling for more than one million USD every year to this emerging market". Currently Orion Integrated Biosciences Inc. is distributing products of the BAYER Crop Science Division and the same time as part of its corporate responsibility, Orion Integrated Biosciences Inc. has began its effort to plant more than 250,000 trees in the next three years.

03.08.2007 Orion Integrated Biosciences announced today the intent of the U.S. Defense Threat Reduction Agency to award a US$2.4 million grant to a consortium which includes the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) and Orion Integrated Biosciences Inc. The project will use Orion's genomic signature technology to develop a new generation of small molecule inhibitors against biological warfare agents.

02.27.2007 CHI's THE BIOTECH PHARMA PARTNERHIP. San Francisco, California

01.19.2007 GORDON CONFERENCE ON CHEMICAL & BIOLOGICAL TERRORISM DEFENSE. Ventura, California

01.04.2007PACIFIC SYMPOSIUM ON BIOCOMPUTING. Maui, Hawaii. Orion Integrated Biosciences Inc. introduced in the article "Transcriptional Interactions During Smallpox Infection and Identification of Early Infection Biomarkers" a new algorithm for the identification of smallpox infection biomarkers. Variola major (smallpox) is a deadly disease that can be intentionally reintroduced into the human population as a bioweapon. As the article pointed, while host gene expression microarray profiling can be used to detect infection, the analysis of this information using classical data analysis techniques can produce contradictory results. Orion Integrated Biosciences Inc. researchers developed a novel computational analysis pipeline that incorporates molecular genome annotation features that are key for identifying early infection biomarkers (EIB). Using microarray data, Orion's research team identified 58 EIBs expressed in peripheral blood mononuclear cells (PBMCs) collected from 21 cynomolgus macaques (Macaca fascicularis) infected with two variola strains via aerosol and intravenous exposure. The level of expression of these EIBs was correlated with disease progression and severity. This approach was also used to discover receptors that might be used by the virus to complete replication, assembly, and maturation. Orion Integrated Biosciences Inc. technique is currently used by different clients and collaborators to discover both infection biomarkers for bacterial and viral diseases as well to evaluate the efficacy of vaccines.

12.30.2006 ORION FEATURED IN FORBES/WOLFE NANOTECH REPORT. According with the magazine, Orion Integrated Biosciences Inc. technologies touch (literally) on hot button issues for nanotech: healthcare and pathogen detection. The article pointed that while more than 20 companies claim to be able to recognize different pathogens, none so far have been able to convert this ability into a commercial, mass-manufacturable device. As Orion's CEO Willy Valdivia-Granda pointed, the trouble isn't for lack of sensitive detection technologies but rather it's that few detection systems offer the means to quickly store, retrieve and exchange molecular and diagnostic data. Orion Integrated Biosciences is trying to remedy this situation by combining nanoscale probes with a proprietary genomic database of deadly viral pathogens. The article also discussed the US$8 Million investment that Orion Integrated Biosciences is pursuing to complete mass scale production of cheaper and broad spectrum detection devices for biodefense and sexually transmitted diseases.

11.09.2006 9th ANNUAL BIODETECTION TECHNOLOGIES. San Diego, CA. Orion Integrated Biosciences Inc. presented the progress in the detection of viral pathogens using genomic barcoding technology.

11.13.2007 SCIENTIFIC CONFERENCE ON CHEMICAL & BIOLOGICAL DEFENSE RESEARCH. Hunt Valley, Maryland. Orion Integrated Biosciences researcher presented a new generation of passive and active technologies and algorithms for pathogen detection, identification, mapping and modeling. Two presentations in this important conference disscussed Orion Integrated Biosciences's technology to confirm individual exposure to chemical and biological hazards before symptoms develop.

10.03.2006 The U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) and Orion Integrated Biosciences Inc. have entered into a Cooperative Research and Development Agreement to use of Orion's encephalic and hemorrhagic viruses genomic signatures and barcodes for developing new pathogen detection technologies.